Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function

Journal of Virology

Volumn 76, Issue 18, 2002, Pages 9112-9123

  Khan, Mohammad A ^a   Akari, Hirofumi ^a   Kao, Sandra ^a   Aberham, Claudia ^a   Davis, David ^a   Buckler White, Alicia ^a   Strebel, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RITONAVIR; VIF PROTEIN; VIRUS NUCLEOPROTEIN; VIRUS RNA;

ARTICLE; CELL TYPE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STABILITY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELL LINE; GENE PRODUCTS, VIF; HELA CELLS; HIV PROTEASE; HIV-1; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; MUTATION; VIRION; VIRUS REPLICATION;

EID: 0036720794     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.18.9112-9123.2002     Document Type: Article

References (64)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
2. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells
3. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: Functional difference between Vif and Nef
4. Human immunodeficiency virus type 1 Vifderived peptides inhibit the viral protease and arrest virus production
5. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: Co-encapsidation and interference with viral protease-mediated Gag processing
6. - HIV-1 mutants in CEM cells suggests that Vif affects late steps of the viral life cycle
7. - mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
8. Gag precursor
9. - human immunodeficiency virus type 1 is produced by chronically infected restrictive cells
10. Characterization of human immunodeficiency virus type 1 Vif particle incorporation
11. Vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus
12. - human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps
13. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription
14. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
15. Partial rescue of the vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription
16. Cell-free transmission of Vif mutants of HIV-1
17. The sor gene of HIV-1 is required for efficient virus transmission in vitro
18. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
19. Peptides derived from HIV-1 Vif: A non-substrate based novel type of HIV-1 protease inhibitors
20. + T lymphocytes
21. Subcellular localization of the Vif protein of human immunodeficiency virus type 1
22. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains
23. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral Vif protein
24. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure
25. Role of vif during packing of the core of HIV-1
26. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
27. Interaction and coencapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins
28. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein
29. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA
30. Cells surviving infection by human immunodeficiency virus type 1: Vif or vpu mutants produce non-infectious or markedly less cytopathic viruses
31. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro
32. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures
33. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity
34. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
35. The HIV-1 protease as enzyme and substrate: Mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties
36. Conservation of amino-acid sequence motifs in lentivirus Vif proteins
37. Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1
38. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1
39. Role of Vif in stability of the human immunodeficiency virus type 1 core
40. Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif
41. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants
42. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
43. Mutational analysis of human immunodeficiency virus type 1 vif gene
44. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing
45. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
46. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells
47. Evidence for a newly discovered cellular anti-HIV-1 phenotype
48. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
49. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function
50. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: A role for Vif in determining virus host range and cross-species transmission
51. Mutational analysis of the human immunodeficiency virus type 1 Vif protein
52. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes
53. The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions
54. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed Gag
55. The HIV 'A' (sor) gene product is essential for virus infectivity
56. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
57. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase
58. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160
59. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity
60. The multimerization of human immunodeficiency virus type I Vif protein: A requirement for Vif function in the viral life cycle
61. Phosphorylation of Vif and its role in HIV-1 replication
62. A general method for the generation of high-titer, pantropic retroviral vectors: HIghly efficient infection of primary hepatocytes
63. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process
64. Identification of a host protein essential for assembly of immature HIV-1 capsids